S.2217 - Federal Research Investment Act105th Congress (1997-1998)
|Sponsor:||Sen. Frist, William H. [R-TN] (Introduced 06/25/1998)|
|Committees:||Senate - Commerce, Science, and Transportation | House - Science; Commerce; National Security; Resources; Agriculture|
|Committee Reports:||S. Rept. 105-364|
|Latest Action:||House - 10/27/1998 Referred to the Subcommittee on Health and Environment, and in addition to the Subcommittees on Telecommunications, Trade, and Consumer Protection, Energy and Power, and Finance and Hazardous Materials, for a period to be subsequently determined by the Chairman. (All Actions)|
This bill has the status Passed Senate
Here are the steps for Status of Legislation:
- Passed Senate
Summary: S.2217 — 105th Congress (1997-1998)All Information (Except Text)
Passed Senate amended (10/08/1998)
Federal Research Investment Act - Calls for Federal funding levels for fundamental, scientific, and pre-competitive engineering research to be increased to equal approximately 2.6 percent of the total annual Federal budget. Authorizes appropriations for civilian research and development (R&D) within specified agencies for FY 1999 through 2010.
Directs the President to include with the annual budget request a report concerning Federal R&D program funding, future R&D strategies and targets, an analysis of funding levels across Federal agencies by funding methodology, and specific proposals for infrastructure development and R&D capacity building in States with less concentrated R&D resources.
Requires the Director of the Office of Science Technology Policy to enter in an agreement with the National Academy of Sciences to conduct a comprehensive study to develop methods for evaluating federally-funded R&D programs. Requires the Director of the Office of Management and Budget (OMB), based on study results, to promulgate one or more alternative forms for Federal R&D performance goals. Permits an agency head to apply such an alternative form without further authorization by OMB. Requires agency heads carrying out R&D activities, upon updating a strategic plan, to describe the current and future use of methods for determining an acceptable level of R&D success as recommended by the study. Authorizes appropriations for the study.
Requires the OMB Director, based upon program performance reports, to identify the civilian R&D program activities or components which do not meet an acceptable level of success as defined under current law. Directs the head of an agency, for each program activity or component identified as being below the acceptable level of success for two consecutive fiscal years, to: (1) submit to the appropriate congressional committees a concise statement of the steps that will be taken to bring such program into compliance with performance goals; or (2) terminate such program should compliance efforts fail. Requires the inclusion of any legislative changes needed to effectuate the steps contained in such statement.